Serum prolactin in advanced chronic liver disease

Hormone and Metabolic Research

Volumn 46, Issue 11, 2014, Pages 800-803

  Ress, C ^a   Maeser, P A ^a   Tschoner, A ^a   Loacker, L ^a   Salzmann, K ^a   Staudacher, G ^a   Melmer, A ^a   Zoller, H ^a   Vogel, W ^a   Griesmacher, A ^a   Tilg, H ^a   Graziadei, I ^a,b   Kaser, S ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b Division of Internal Medicine   (Austria)

Author keywords

Child Pugh score; liver cirrhosis; prolactin

Indexed keywords

EID: 84899779386     PISSN: 00185043     EISSN: 14394286     Source Type: Journal    
DOI: 10.1055/s-0034-1375612     Document Type: Article

References (31)

1. Klibanski A. Clinical practice. Prolactinomas. N Engl J Med: 2010; 362 1219 1226
2. Burra P. Liver abnormalities and endocrine diseases. Best Pract Res Clin Gastroenterol: 2013; 27 553 563
3. Ninkovic M., Love S. A., Tom B., Alexander G. J., Compston J. E. High prevalence of osteoporosis in patients with chronic liver disease prior to liver transplantation. Calcif Tissue Int: 2001; 69 321 326
4. Compston J. E. Osteoporosis after liver transplantation. Liver Transpl: 2003; 9 321 330
5. Morgan M. Y., Jakobovits A. W., Gore M. B., Wills M. R., Sherlock S. Serum prolactin in liver disease and its relationship to gynaecomastia. Gut: 1978; 19 170 174
6. Zietz B., Lock G., Plach B., Drobnik W., Grossmann J., Scholmerich J., Straub R. H. Dysfunction of the hypothalamic-pituitary-glandular axes and relation to Child-Pugh classification in male patients with alcoholic and virus-related cirrhosis. Eur J Gastroenterol Hepatol: 2003; 15 495 501
7. De A., Boyadjieva N., Pastorcic M., Sarkar D. Potentiation of the mitogenic effect of estrogen on the pituitary-gland by alcohol-consumption. Int J Oncol: 1995; 7 643 648
8. Sengupta A., Sarkar D. K. Roles of dopamine 2 receptor isoforms and g proteins in ethanol regulated prolactin synthesis and lactotropic cell proliferation. PloS One: 2012; 7 e45593
9. Murdoch F. E., Byrne L. M., Ariazi E. A., Furlow J. D., Meier D. A., Gorski J. Estrogen receptor binding to DNA: affinity for nonpalindromic elements from the rat prolactin gene. Biochemistry: 1995; 34 9144 9150
10. Malayer J. R., Gorski J. The role of estrogen receptor in modulation of chromatin conformation in the 5′ flanking region of the rat prolactin gene. Mol Cell Endocrinol: 1995; 113 145 154
11. Gordon G. G., Olivo J., Rafil F., Southren A. L. Conversion of androgens to estrogens in cirrhosis of the liver. J Clin Endocrinol Metab: 1975; 40 1018 1026
12. Seehofer D., Steinmueller T., Graef K. J., Rayes N., Wiegand W., Tullius S. G., Settmacher U., Neuhaus P. Pituitary function test and endocrine status in patient with cirrhosis of the liver before and after hepatic transplantation. Ann Transplant: 2002; 7 32 37
13. Velissaris D., Karanikolas M., Kalogeropoulos A., Solomou E., Polychronopoulos P., Thomopoulos K., Labropoulou-Karatza C. Pituitary hormone circadian rhythm alterations in cirrhosis patients with subclinical hepatic encephalopathy. World J Gastroenterol: 2008; 14 4190 4195
14. Sadideen H., Swaminathan R. Macroprolactin: what is it and what is its importance? Int J Clin Pract: 2006; 60 457 461
15. Madhusoodanan S., Parida S., Jimenez C. Hyperprolactinemia associated with psychotropics - a review. Hum Psychopharmacol: 2010; 25 281 297
16. Mertens B., Vanderheyden P., Michotte Y., Sarre S. Direct angiotensin II type 2 receptor stimulation decreases dopamine synthesis in the rat striatum. Neuropharmacology: 2010; 58 1038 1044
17. Mediskou P., Yavropoulou M. P., Kotsa K., Tsekmekidou X., Psarakou-Gotzamani A., Papazisi A., Chlorou A., Yovos J. G. The renin-angiotensin-aldosterone axis in patients with nontumoral [corrected] hyperprolactinemia. Clin Endocrinol: 2011; 74 306 311
18. Farthing M. J., Green J. R., Edwards C. R., Dawson A. M. Progesterone, prolactin, and gynaecomastia in men with liver disease. Gut: 1982; 23 276 279
19. Chahal J., Schlechte J. Hyperprolactinemia. Pituitary: 2008; 11 141 146
20. Melmed S., Casanueva F. F., Hoffman A. R., Kleinberg D. L., Montori V. M., Schlechte J. A., Wass J. A., Endocrine S. Diagnosis and treatment of hyperprolactinemia: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab: 2011; 96 273 288
21. Bernichtein S., Touraine P., Goffin V. New concepts in prolactin biology. J Endocrinol: 2010; 206 1 11
22. Ignacak A., Kasztelnik M., Sliwa T., Korbut R. A., Rajda K., Guzik T. J. Prolactin-not only lactotrophin. A new view of the old hormone. J Physiol Pharmacol: 2012; 63 435 443
23. Olazabal I. M., Munoz J. A., Rodriguez-Navas C., Alvarez L., Delgado-Baeza E., Garcia-Ruiz J. P. Prolactin's role in the early stages of liver regeneration in rats. J Cell Physiol: 2009; 219 626 633
24. Kloehn S., Otte C., Korsanke M., Arendt T., Clemens A., Glasow A., Bornstein S. R., Folsch U. R., Monig H. Expression and distribution of the prolactin receptor in normal rat liver and in experimental liver cirrhosis. Horm Metab Res: 2001; 33 394 401
25. Simon-Holtorf J., Monig H., Klomp H. J., Reinecke-Luthge A., Folsch U. R., Kloehn S. Expression and distribution of prolactin receptor in normal, fibrotic, and cirrhotic human liver. Exp Clin Endocrinol Diabetes: 2006; 114 584 589
26. Biller B. M. Diagnostic evaluation of hyperprolactinemia. J Reprod Med: 1999; 44 1095 1099
27. George J., Ganesh H. K., Acharya S., Bandgar T. R., Shivane V., Karvat A., Bhatia S. J., Shah S., Menon P. S., Shah N. Bone mineral density and disorders of mineral metabolism in chronic liver disease. World J Gastroenterol: 2009; 15 3516 3522
28. Fahie-Wilson M. N., Soule S. G. Macroprolactinaemia: contribution to hyperprolactinaemia in a district general hospital and evaluation of a screening test based on precipitation with polyethylene glycol. Ann Clin Biochem: 1997; 34 252 258
29. Olukoga A. O., Kane J. W. Macroprolactinaemia: validation and application of the polyethylene glycol precipitation test and clinical characterization of the condition. Clin Endocrinol: 1999; 51 119 126
30. Shimatsu A., Hattori N. Macroprolactinemia: diagnostic, clinical, and pathogenic significance. Clin Dev Immunol: 2012; 2012 167132
31. Lim V. S., Kathpalia S. C., Frohman L. A. Hyperprolactinemia and impaired pituitary response to suppression and stimulation in chronic renal failure: reversal after transplantation. J Clin Endocrinol Metab: 1979; 48 101 107